TXTM (ProText Mobility) Operating Margin %: -26,100.00% (As of Sep. 2014)


What is ProText Mobility Operating Margin %?

ProText Mobility TXTM Operating Margin % is -26,100.00% as of Sep. 2014.

Operating Margin % is calculated as Operating Income divided by its Revenue. ProText Mobility's Operating Income for the three months ended in Sep. 2014 was $-0.26 Mil. ProText Mobility's Revenue for the three months ended in Sep. 2014 was $0.00 Mil. Therefore, ProText Mobility's Operating Margin % for the quarter that ended in Sep. 2014 was -26,100.00%.

The historical rank and industry rank for ProText Mobility's Operating Margin % or its related term are showing as below:


TXTM's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -86.89
* Ranked among companies with meaningful Operating Margin % only.

ProText Mobility's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

ProText Mobility's Operating Income for the three months ended in Sep. 2014 was $-0.26 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2014 was $-1.03 Mil.


ProText Mobility  (OTCPK:TXTM) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


ProText Mobility Operating Margin % Related Terms


ProText Mobility Operating Margin % Historical Data

* Premium members only.

The historical data trend for ProText Mobility's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProText Mobility Operating Margin % Chart

ProText Mobility Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12,658.06 -14,509.68 -10,634.62 -13,800.00 -92,700.00

ProText Mobility Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -26,100.00

TXTM vs DRSV, YPPN, CYBF: Operating Margin % Comparison

For the Biotechnology subindustry, ProText Mobility's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProText Mobility Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's Operating Margin % distribution charts can be found below:

* The bar in red indicates where ProText Mobility's Operating Margin % falls into.



ProText Mobility Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

ProText Mobility's Operating Margin % for the fiscal year that ended in Dec. 2013 is calculated as

Operating Margin %=Operating Income (A: Dec. 2013 ) / Revenue (A: Dec. 2013 )
=-0.927 / 0.001
=-92,700.00 %

ProText Mobility's Operating Margin % for the quarter that ended in Sep. 2014 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2014 ) / Revenue (Q: Sep. 2014 )
=-0.261 / 0.001
=-26,100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -26,100.00% mean?
ProText Mobility (TXTM) has a Operating Margin % of -26,100.00% as of Sep. 2014. Operating margin is the ratio of total operating income to net sales. View historical data on ProText Mobility and its competitors.
Is ProText Mobility's Operating Margin % too high?
ProText Mobility's current Operating Margin % is -26,100.00%.
How does ProText Mobility's Operating Margin % compare to DRSV and YPPN?
ProText Mobility's Operating Margin % of -26,100.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on ProText Mobility and its competitors. ProText Mobility's current Operating Margin % is -26,100.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProText Mobility stock overvalued right now?
ProText Mobility (TXTM) has a current Operating Margin % of -26,100.00%. The current Operating Margin % is -26,100.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For ProText Mobility (TXTM), the current Operating Margin % is -26,100.00% as of Sep. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProText Mobility Business Description

Address One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301
ProText Mobility Inc is a Biotech Company developing a Hemp/CBD-Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products, all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.